Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 6 (12), 5933-54

Simple Sugar Intake and Hepatocellular Carcinoma: Epidemiological and Mechanistic Insight

Affiliations
Review

Simple Sugar Intake and Hepatocellular Carcinoma: Epidemiological and Mechanistic Insight

Juan Carlos Laguna et al. Nutrients.

Abstract

Sugar intake has dramatically increased during the last few decades. Specifically, there has been a clear trend towards higher consumption of fructose and high fructose corn syrup, which are the most common added sugars in processed food, soft drinks and other sweetened beverages. Although still controversial, this rising trend in simple sugar consumption has been positively associated with weight gain and obesity, insulin resistance and type 2 diabetes mellitus and non-alcoholic fatty liver disease. Interestingly, all of these metabolic alterations have also been related to the development of hepatocellular carcinoma. The purpose of this review is to discuss the evidence coming from epidemiological studies and data from animal models relating the consumption of simple sugars, and specifically fructose, with an increased risk of hepatocellular carcinoma and to gain insight into the putative molecular mechanisms involved.

Figures

Figure 1
Figure 1
Proposed mechanisms by which fructose may promote hepatocellular carcinoma.

Similar articles

See all similar articles

Cited by 13 articles

See all "Cited by" articles

References

    1. Ezzati M., Riboli E. Behavioral and dietary risk factors for noncommunicable diseases. N. Engl. J. Med. 2013;369:954–964. doi: 10.1056/NEJMra1203528. - DOI - PubMed
    1. Zheng Z., Zhang C., Yan J., Ruan Y., Zhao X., San X., Mao Y., Sun Q., Zhang K., Fan Z. Diabetes mellitus is associated with hepatocellular carcinoma: a retrospective case-control study in hepatitis endemic area. PLoS One. 2013;8 doi: 10.1371/journal.pone.0084776. - DOI - PMC - PubMed
    1. Jinjuvadia R., Patel S., Liangpunsakul S. The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis. J. Clin. Gastroenterol. 2014;48:172–177. doi: 10.1097/MCG.0b013e3182a030c4. - DOI - PMC - PubMed
    1. Atchison E., Gridley G., Carreon J., Leitzmann M., McGlynn K. Risk of cancer in a large cohort of U.S. veterans with diabetes. Int. J. Cancer. 2011;128:635–643. doi: 10.1002/ijc.25362. - DOI - PMC - PubMed
    1. Turati F., Talamini R., Pelucchi C., Polesel J., Franceschi S., Crispo A, Izzo F., La Vecchia C., Boffetta P., Montella M. Metabolic syndrome and hepatocellular carcinoma risk. Br. J. Cancer. 2013;108:222–228. doi: 10.1038/bjc.2012.492. - DOI - PMC - PubMed

Publication types

Feedback